Antibodies binding to the A2 domain of FVIII and inhibiting...

Details Antibodies binding to the A2 domain of FVIII and inhibiting... Antibodies binding to the A2 domain of FVIII and inhibiting...

2006-07-31

2010-12-28

Szperka, Michael (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S141100, C424S145100, C424S146100, C514S013700, C514S014100

Reexamination Certificate

active

07858089

ABSTRACT:
The present invention relates to new antibodies and fragments and derivatives thereof. These antibodies bind to the A2 domain of Factor VIII (FVIII) of the coagulation pathway and inhibit the coagulation activity of FVIII. The antibodies are particularly suited for the characterization of the structure and function of FVIII, for the design of therapeutic strategies for eradication of FVIII inhibitors and for the use as a medicament. The invention also relates to cell lines producing the specific antibodies. The present invention furthermore relates to pharmaceutical compositions comprising the antibodies, fragments and/or derivatives of the invention and to methods of preventing and treating cardiovascular disorders by using the antibodies or fragments and derivatives thereof or pharmaceutical compositions thereof.

REFERENCES:
patent: 5693762 (1997-12-01), Queen et al.
patent: 2004/0120951 (2004-06-01), Nakashima et al.
patent: 1 222 929 (2002-07-01), None
patent: 1 396 539 (2004-03-01), None
patent: WO 01/04269 (2001-01-01), None
patent: WO 2005/046583 (2005-05-01), None
van den Brink et al., Blood, 2000, 96:540-545.
Rudikoff et al., Proc Natl Acad Sci U S A. Mar. 1982;79(6):1979-83.
Janeway et al., Immunobiology, 3rd edition, 1997, Garland Press, pp. 3:1 to 3:11.
William E. Paul, M.D. ed., Fundamental Immunology, 3d ed. 1993, p. 242.
Portolano et al., J Immunol., 1993, 150:880-887.
Aortic Regurgitation: Heart Valve Disorders: Merck Manual Home Edition, downloaded May 25, 2010.
Marfan Syndrome:Hereditary Connective Tissue Disorders:: Merck Manual Home Edition, downloaded May 25, 2010.
Communication from the European Patent Office issued in connection with European Patent Application No. 06 776 526.3, dated Feb. 4, 2010.
Davies et al., “Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding,”Immunotechnology2: 169-179 (1996).
Healey et al., “Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII,”The Journal of Biological Chemistry270(24): 14505-14509 (1995).
Holt et al., “Domain antibodies: proteins for therapy,”TRENDS in Biotechnology21(11): 484-490 (2003).
Scandella et al., “Localization of Epitopes for Human Factor VIII Inhibitor Antibodies by Immunoblotting and Antibody Neutralization,”Blood74(5): 1618-1626 (1989).
Stoilova-McPhie et al., “3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography,”Blood99(4): 1215-1223 (2002).
Van den Brink et al., “Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain,”Blood96(2): 540-545 (2000).
International Search Report (PCT/EP2006/007564), mailed Jan. 30, 2007.
Written Opinion (PCT/EP2006/007564), mailed Jan. 30, 2007.
Response to the Written Opinion dated Jan. 30, 2007, mailed May 29, 2007.
Notification Concerning Informal Communication with the Applicant, mailed Sep. 10, 2007.
Response to “Notification Concerning Informal Communication with the Applicant,” dated Sep. 17, 2007.
Notification of Transmittal of the International Preliminary Report on Patentability, mailed Oct. 11, 2007.

Affiliated with

Also associated with

Rating

Antibodies binding to the A2 domain of FVIII and inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies binding to the A2 domain of FVIII and inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies binding to the A2 domain of FVIII and inhibiting... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4179555